Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment

BACKGROUND: Interferon beta (IFNβ) has been prescribed as a first-line disease-modifying therapy for relapsing-remitting multiple sclerosis (RRMS) for nearly three decades. However, there is still a lack of treatment response markers that correlate with the clinical outcome of patients. AIM: To dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Devi-Marulkar, Priyanka, Moraes-Cabe, Carolina, Campagne, Pascal, Corre, Béatrice, Meghraoui-Kheddar, Aida, Bondet, Vincent, Llibre, Alba, Duffy, Darragh, Maillart, Elisabeth, Papeix, Caroline, Pellegrini, Sandra, Michel, Frédérique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185344/
https://www.ncbi.nlm.nih.gov/pubmed/34113337
http://dx.doi.org/10.3389/fimmu.2021.628375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185344/
https://www.ncbi.nlm.nih.gov/pubmed/34113337
http://dx.doi.org/10.3389/fimmu.2021.628375

Ejemplares similares